Monday, January 17, 2022

Why Theranos failed, but other researchers might not

- Advertisement -
- Advertisement -
- Advertisement -


Jurors are nonetheless deliberating over the destiny of Elizabeth Holmes, the founding father of defunct biotech firm Theranos. They’re deciding if she deliberately misled buyers, sufferers, and docs about what her firm’s blood testing expertise might do. Because regardless of large guarantees, the tech the corporate claimed to have invented… didn’t really exist.

And the expertise might by no means be a actuality — no less than not in the way in which Holmes described it. In this episode of our three-part sequence on Theranos, we have a look at what researchers really assume is feasible within the discipline of blood testing and what the longer term might appear to be.



Source hyperlink

- Advertisement -

More from the blog

Oppo’s next flagship leaks with OnePlus-esque Hasselblad branding

Details on Oppo’s upcoming flagship cellphone are beginning to come collectively. Multiple leaks are suggesting it’ll be referred to as the...

The trials and tribulations of turning a real camera into a webcam

My colleague Dieter Bohn is one of the nicest folks I’ve met, however each time I’d hop onto Zoom to report...

Google is now requiring office workers to get weekly molecular COVID-19 tests

Google would require anybody going to one among its US places of work or amenities to have obtained a destructive molecular...

The FTC is reportedly investigating Meta’s VR division for antitrust violations

The US Federal Trade Commission and at the very least three states are investigating Meta for antitrust violations in its digital...